Insulin-like growth factor-binding protein 2 (IGFBP2), secreted by metastatic breast cancer cells, contributes to metastatic bone colonization by interacting with IGF type-1 receptor on endothelial cells through endothelial recruitment [56]. This evidence concerns the gene IGFBP2 and breast cancer.